𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Control of dynamic stability during gait termination on a slippery surface in Parkinson's disease

✍ Scribed by Alison R. Oates; Jim S. Frank; Aftab E. Patla; Karen VanOoteghem; Fay B. Horak


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
222 KB
Volume
23
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

This study investigated how Parkinson's disease (PD) affects the ability to switch from locomotion to gait termination (GT) during planned and cued GT and examined the effect of PD on the integration of a reactive, balance maintenance strategy into voluntary GT. After a series of stops on a stable surface, eight participants with and 10 without PD stopped on a surface, which slid quickly and unexpectedly forward mimicking a slippery surface. PD caused instability during the completely voluntary nonslippery stops (P = 0.012) but not during the slippery stops, which required a reactive movement. The PD group walked slower [0.9–1.0 m/s vs. 1.3 m/s, respectively (P < 0.001)] with shorter steps during the first step of nonslippery GT (P = 0.016) and with wider steps during all steps of nonslippery GT (P ≤ 0.05). Similar to controls, the PD group increased lateral stability during planned GT compared to cued GT (P = 0.007). The timing of gait termination was similar between groups in all conditions. During the unexpected perturbation, both groups used a generalized slip response to regain balance after the perturbation. PD did not affect the ability to stop walking or to integrate a balance‐correcting response into GT but did affect movement speed, size, and stability of the voluntary movement. © 2008 Movement Disorder Society


📜 SIMILAR VOLUMES


The effect of injecting botulinum toxin
✍ Tanya Gurevich; Chava Peretz; Orna Moore; Nina Weizmann; Nir Giladi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

## Abstract ## Objective To assess the effect on freezing of gait (FOG) of botulinum toxin type A (BTX‐A) injections in advanced Parkinson's disease (PD) patients. ## Method BTX‐A 150 IU or normal saline was injected into each leg's calf muscles by a blinded investigator. FOG severity was assess